Srijita Banerjee Molecular Cell Biology, Doctoral Candidate
No reviews yet

I would teach through visual aids and also refer a lot to current research (Citing papers) in whatever topic I am teaching. The latter would help students a lot to learn about new about newer research and advancements in their topic of interest.
I have also taught students in the lab while I was doing my master's thesis. Although mostly in the lab, I was able to deliver the science behind the project through nice diagrammatic representations to the student where I was highly appreciated.
I am quite confident with making nice schematic presentations, I do a lot of that for my research. This, I believe is a great way to learn and understand signalling pathways and techniques in biology.
Last but not least I have good communication skills and adaptability. I enjoy reading scientific literature and also transferring the knowledge I have gained which I also believe makes me a good teacher.

Subjects

  • Cell Biology Beginner-Expert

  • Molecular Biology Beginner-Expert

  • Cancer Biology Bachelors/Undergraduate-Masters/Postgraduate

  • Biophysics Beginner-Intermediate

  • Bio signalling Beginner-Expert

Experience

  • Master Thesis Student (Jan, 2022–Oct, 2022) at Deutsches Krebsforschungszentrum (DKFZ)
    Targeting lipid-receptor interactions to block cancer progression; Molecular Neurobiology; German Cancer Research Centre, Heidelberg, Germany
    CD95, importantly known to be a death receptor leading to apoptosis has been observed to be leading to proliferation and survivability in Glioblastoma multiforme through changes in the global phosphor tyrosine levels. Investigation of the interaction of CD95 with membrane lipids and proteins has led to an understanding of the activation switch of the CD95 pathway. To explore the regulatory mechanism of CD95 activation for anti-cancer therapies, we have generated transmembrane domain mutants of CD95, which have been shown to affect the signalling pathways. Local changes in lipid-protein interactions have also been observed, affecting different cell uptake processes. Our study sheds light on the regulatory mechanisms of CD95 activation and its several interaction partners that can be further explored for anti-cancer therapies.
  • Research Internship (Apr, 2021–Dec, 2021) at Karolinska institute, Stockholm, Sweden
    Evaluating combined anti-Myc/CDK4 pro-senescence therapy as a new strategy for treatment of malignant melanoma, Lars-Gunnar Larsson Group, Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Solna, Sweden
    To asses the concept of “Pro-senescence therapy” in melanoma we performed a senescence screen utilizing a panel of melanoma cell lines. We evaluated the potential of combination therapy between a pre-clinically used CDK4/6 inhibitor, palbociclib together with the MYC inhibitors. Toxicity levels, senescence induction, protein expression levels and also immune marker expression levels were analysed for different cell lines on drug treatment. In summary, the targeted drugs alone or in combination, induced senescence with the potential to trigger immuno-clearance in a broad range of melanoma cell lines. Our findings suggest that pro-senescence therapy can potentially be used as an alternative treatment strategy for melanoma.
  • Research Internship (Dec, 2020–Feb, 2021) at Deutsches Krebsforschungszentrum (DKFZ)
    Vascular regulation of tissue structure; Vascular Signalling and Cancer; German Cancer Research Centre, Heidelberg, Germany
    In ovarian cancer metastasis usually happens when tumor cells usually feed on the omentum ultimately leading to tumor growth through immunological and metabolic mechanisms. Omentum as an organ/adipose tissue constitutes of remarkable angiogenic, fibrotic, stem cell and immune properties which conjointly promote vascularization, escalate wound healing and limit infection, similar activities playing a role in pathological responses which includes rapid growth of omental tumour metastasis. In this work, I developed and optimised a precise whole mount staining procedure for the omental tissue samples followed by a one-step clearing agent that allows visualisation of normal tissue architecture at cellular resolution. This protocol in future can be used to understand the vascular and cellular content of the tumor infiltrated omental tissues.
  • Technical Assistant (Mar, 2020–Mar, 2021) at Deutsches Krebsforschungszentrum (DKFZ)
    Genotypic of mouse tails, plasmid and virus preperation

Education

  • Doctoral candidate in Medical pharmacy (Apr, 2023–now) from Uppsala University Sweden
  • Master of Science (Oct, 2019–Oct, 2022) from Heidelberg University, Germany

Fee details

    €10–15/hour (US$11.11–16.67/hour)

    I would mostly teach online thus it would not vary much

Reviews

No reviews yet. Be the first one to review this tutor.